Advertisement

European Journal of Epidemiology

, Volume 34, Issue 2, pp 141–152 | Cite as

Vision loss and 12-year risk of dementia in older adults: the 3C cohort study

  • Virginie NaëlEmail author
  • Karine Pérès
  • Jean-François Dartigues
  • Luc Letenneur
  • Hélène Amieva
  • Angelo Arleo
  • Anne-Catherine Scherlen
  • Christophe Tzourio
  • Claudine Berr
  • Isabelle Carrière
  • Cécile Delcourt
  • Catherine Helmer
  • the Sense-Cog consortium
OPHTALMIC EPIDEMIOLOGY

Abstract

To analyze the longitudinal relationships between vision loss and the risk of dementia in the first 2 years, from 2 to 4 years and beyond 4 years after inclusion and to determine the roles of depressive symptomatology and engagement in cognitively stimulating activities in these associations. This study is based on the Three-City (3C) study, a population-based cohort of 7736 initially dementia-free participants aged 65 years and over with 12 years of follow-up. Near visual impairment (VI) was measured and distance visual function (VF) loss was self-reported. Dementia was diagnosed and screened over the 12-year period. At baseline, 8.7% had mild near VI, 4.2% had moderate to severe near VI, and 5.3% had distance VF loss. Among the 882 dementia cases diagnosed over the 12-year follow-up period, 140 cases occurred in the first 2 years, 149 from 2 to 4 years and 593 beyond 4 years after inclusion. In Cox multivariate analysis, moderate to severe near VI was associated with an increased risk of dementia in the first 2 years (HR 2.0, 95% CI 1.2–3.3) and from 2 to 4 years (HR 1.8, 95% CI 1.1–3.1) but the association was not significant beyond 4 years after inclusion even if pointing in similar direction (HR 1.3, 95% CI 0.95–1.9). Mild near VI was associated with an increased risk of dementia only in the first 2 years (HR 1.6, 95% CI 1.1–2.5). Moreover, self-reported distance VF loss was associated with an increased risk beyond 4 years after inclusion (HR 1.5, 95% CI 1.1–2.0) but the association was no longer significant after taking into account baseline cognitive performances. Further adjustment for engagement in cognitively stimulating activities only slightly decreased these associations. However, there was an interaction between vision loss and depressive symptomatology, with vision loss associated with dementia only among participants with depressive symptomatology. These results suggest that poor vision, in particular near vision loss, may represent an indicator of dementia risk at short and middle-term, mostly in depressed elderly people.

Keywords

Vision loss Dementia Cohort study Epidemiology 

Notes

Acknowledgements

Study funding: The Three-City study is conducted under a partnership agreement between the Institut National de la Santé et de la Recherche Médicale (INSERM), the University Bordeaux 2 Victor Segalen and Sanofi-Aventis. The Fondation pour la Recherche Médicale funded the preparation and initiation of the study. The Three-City study is also supported by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Conseils Régionaux d’Aquitaine et Bourgogne, Fondation de France, Ministry of Research-INSERM Programme “Cohortes et collections de données biologiques”, Agence Nationale de la Recherche ANR PNRA 2006 and LongVie 2007, the “Fondation Plan Alzheimer” (FCS 2009-2012) and the Caisse Nationale de Solidarité pour l’Autonomie (CNSA). None of the sponsors participated in the collection, management, statistical analysis and interpretation of the data, nor in the preparation, review or approval of the present manuscript. SENSE-Cog has received funding from the European Union’s Horizon 2020 research and innovation program under Grant agreement No. 668648.

List of Sense-Cog Consortium: Geir Bertelsen1,2, Suzanne Cosh3, Audrey Cougnard-Grégoire3, Piers Dawes4, Cécile Delcourt3, Fofi Constantinidou5, Catherine Helmer3, M. Arfan Ikram 6,7, Caroline CW Klaver 6,8, Iracema Leroi 9, Asri Maharani 9,10, Magda Meester-Smor 6,8, Unal Mutlu 6,8, Virginie Nael3,11,12, Neil Pendleton 9,10, Henrik Schirmer 13, Gindo Tampubolon 14, Henning Tiemeier 6,15, Therese von Hanno 16,17.

1: UiT The Arctic University of Norway, Department of Community Medicine, Faculty of Health Sciences, N-9037 Tromsø, Norway

2: University Hospital of North Norway, Department of Ophthalmology, N-9038 Tromsø, Norway

3: Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team LEHA, UMR 1219, F-33000 Bordeaux, France

4: University of Manchester, Manchester Centre for Audiology and Deafness, School of Health Sciences, Manchester, UK

5: University of Cyprus, Department of Psychology & Center for Applied Neuroscience, Nicosia, Cyprus

6: Erasmus Medical Centre, Department of Epidemiology, Rotterdam, The Netherlands

7: Erasmus Medical Centre, Departments of Neurology and Radiology, Rotterdam, The Netherlands

8: Erasmus Medical Centre, Department of Ophthalmology, Rotterdam, The Netherlands

9: University of Manchester, Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Manchester, UK

10: University of Manchester, Academic Health Science Centre, Manchester, UK

11: Sorbonne University, UMPC University of Paris 06, INSERM, CNRS, Vision Institute, F-75012 Paris, France

12: R&D Life and Vision Science, Essilor International, F-75012 Paris, France

13: UiT-The Arctic University of Norway, Department of Clinical Medicine, Cardiovascular research Group-UNN, N-9037 Tromsø, Norway

14: University of Manchester, Global Development Institute, Manchester, UK

15: Erasmus Medical Centre, Department of Psychiatry, Rotterdam, The Netherlands

16: UiT-The Arctic University of Norway, Department of Clinical Medicine, Faculty of Health Sciences, N-9037 Tromsø, Norway

17: Nordland Hospital, Department of Ophthalmology, N-8092 Bodø, Norway

Compliance with ethical standards

Conflict of interest

Authors V. Naël and AC Scherlen are Essilor International employees. Author C. Delcourt is a consultant for Bausch & Lomb, Novartis, and Laboratoires Théa and has received research grants from Laboratoires Théa. The authors K. Pérès, JF. Dartigues, L. Letenneur, H. Amieva, A. Arleo, I. Carrière, C. Tzourio, C. Berr and C. Helmer declare that they have no conflict of interest.

Research involving human participants

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Kremlin-Bicêtre University Hospital and Sud-Mediterranée III committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Supplementary material

10654_2018_478_MOESM1_ESM.docx (16 kb)
Supplementary material 1 (DOCX 15 kb)
10654_2018_478_MOESM2_ESM.docx (14 kb)
Supplementary material 2 (DOCX 14 kb)

References

  1. 1.
    Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, et al. Causes of vision loss worldwide, 1990–2010: a systematic analysis. Lancet Glob Health. 2013;1:e339–49.CrossRefGoogle Scholar
  2. 2.
    Chen SP, Bhattacharya J, Pershing S. Association of vision loss with cognition in older adults. JAMA Ophthalmol. 2017;135:963–70.CrossRefGoogle Scholar
  3. 3.
    Spierer O, Fischer N, Barak A, Belkin M. Correlation between vision and cognitive function in the elderly: a cross-sectional study. Medicine (Baltimore). 2016;95:e2423.CrossRefGoogle Scholar
  4. 4.
    Mine M, Miyata K, Morikawa M, Nishi T, Okamoto N, Kawasaki R, et al. Association of visual acuity and cognitive impairment in older individuals: Fujiwara-kyo Eye study. Biores Open Access. 2016;5:228–34.CrossRefGoogle Scholar
  5. 5.
    Garin N, Olaya B, Lara E, Moneta MV, Miret M, Ayuso-Mateos JL, et al. Visual impairment and multimorbidity in a representative sample of the Spanish population. BMC Public Health. 2014;14.Google Scholar
  6. 6.
    Ong SY, Cheung CY, Li X, Lamoureux EL, Ikram MK, Ding J, et al. Visual impairment, age-related eye diseases, and cognitive function: the Singapore Malay Eye study. Arch Ophthalmol. 2012;130:895–900.CrossRefGoogle Scholar
  7. 7.
    Tay T, Wang JJ, Kifley A, Lindley R, Newall P, Mitchell P. Sensory and cognitive association in older persons: findings from an older Australian population. Gerontology. 2006;52:386–94.CrossRefGoogle Scholar
  8. 8.
    Clemons TE, Rankin MW, McBee WL, Age-Related Eye Disease Study Research Group. Cognitive impairment in the Age-Related Eye Disease Study: AREDS report no. 16. Arch Ophthalmol. 2006;124:537–43.CrossRefGoogle Scholar
  9. 9.
    de Kok DS, Teh RO, Pillai A, Connolly MJ, Wilkinson TJ, Moyes SA, et al. What is the relationship between visual impairment and cognitive function in octogenarians? N Z Med J. 2017;130:33–47.PubMedGoogle Scholar
  10. 10.
    Diaz M, Norell M, Belkin J, Singh A, Reinhart W, Lass J. Cognitive profile of elders in an ophthalmic ambulatory setting. Br J Ophthalmol. 2011;95:24–7.CrossRefGoogle Scholar
  11. 11.
    Hong T, Mitchell P, Burlutsky G, Liew G, Wang JJ. Visual impairment, hearing loss and cognitive function in an older population: longitudinal findings from the Blue Mountains Eye Study. PLoS ONE. 2016;11.Google Scholar
  12. 12.
    Fischer ME, Cruickshanks KJ, Schubert CR, Pinto AA, Carlsson CM, Klein BEK, et al. Age-related sensory impairments and risk of cognitive impairment. J Am Geriatr Soc. 2016;64:1981–7.CrossRefGoogle Scholar
  13. 13.
    Valentijn SAM, van Boxtel MPJ, van Hooren SAH, Bosma H, Beckers HJM, Ponds RWHM, et al. Change in sensory functioning predicts change in cognitive functioning: results from a 6-year follow-up in the maastricht aging study. J Am Geriatr Soc. 2005;53:374–80.CrossRefGoogle Scholar
  14. 14.
    Reyes-Ortiz CA, Kuo Y-F, DiNuzzo AR, Ray LA, Raji MA, Markides KS. Near vision impairment predicts cognitive decline: data from the hispanic established populations for epidemiologic studies of the elderly. J Am Geriatr Soc. 2005;53:681–6.CrossRefGoogle Scholar
  15. 15.
    Sloan FA, Ostermann J, Brown DS, Lee PP. Effects of changes in self-reported vision on cognitive, affective, and functional status and living arrangements among the elderly. Am J Ophthalmol. 2005;140:618–27.CrossRefGoogle Scholar
  16. 16.
    Lin MY, Gutierrez PR, Stone KL, Yaffe K, Ensrud KE, Fink HA, et al. Vision impairment and combined vision and hearing impairment predict cognitive and functional decline in older women. J Am Geriatr Soc. 2004;52:1996–2002.CrossRefGoogle Scholar
  17. 17.
    Rogers MAM, Langa KM. Untreated poor vision: a contributing factor to late-life dementia. Am J Epidemiol. 2010;171:728–35.CrossRefGoogle Scholar
  18. 18.
    Katon W, Pedersen HS, Ribe AR, Fenger-Grøn M, Davydow D, Waldorff FB, et al. Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiatry. 2015;72:612–9.CrossRefGoogle Scholar
  19. 19.
    Köhler S, Buntinx F, Palmer K, van den Akker M. Depression, vascular factors, and risk of dementia in primary care: a retrospective cohort study. J Am Geriatr Soc. 2015;63:692–8.CrossRefGoogle Scholar
  20. 20.
    Dartigues JF, Foubert-Samier A, Le Goff M, Viltard M, Amieva H, Orgogozo JM, et al. Playing board games, cognitive decline and dementia: a French population-based cohort study. BMJ Open. 2013;3:e002998.CrossRefGoogle Scholar
  21. 21.
    Ivers RQ, Mitchell P, Cumming RG. Sensory impairment and driving: the Blue Mountains Eye Study. Am J Public Health. 1999;89:85–7.CrossRefGoogle Scholar
  22. 22.
    Laitinen A, Koskinen S, Härkänen T, Reunanen A, Laatikainen L, Aromaa A. A nationwide population-based survey on visual acuity, near vision, and self-reported visual function in the adult population in Finland. Ophthalmology. 2005;112:2227–37.CrossRefGoogle Scholar
  23. 23.
    Carrière I, Delcourt C, Daien V, Pérès K, Féart C, Berr C, et al. A prospective study of the bi-directional association between vision loss and depression in the elderly. J Affect Disord. 2013;151:164–70.CrossRefGoogle Scholar
  24. 24.
    Hong T, Mitchell P, Burlutsky G, Gopinath B, Liew G, Wang JJ. Visual impairment and depressive symptoms in an older Australian cohort: longitudinal findings from the Blue Mountains Eye Study. Br J Ophthalmol. 2015;99:1017–21.CrossRefGoogle Scholar
  25. 25.
    Kiely KM, Anstey KJ, Luszcz MA. Dual sensory loss and depressive symptoms: the importance of hearing, daily functioning, and activity engagement. Front Hum Neurosci. 2013;7:837.CrossRefGoogle Scholar
  26. 26.
    Tsai S-Y, Cheng C-Y, Hsu W-M, Su T-PT, Liu J-H, Chou P. Association between visual impairment and depression in the elderly. J Formos Med Assoc Taiwan Yi Zhi. 2003;102:86–90.PubMedGoogle Scholar
  27. 27.
    Lindenberger U, Baltes PB. Sensory functioning and intelligence in old age: a strong connection. Psychol Aging. 1994;9:339–55.CrossRefGoogle Scholar
  28. 28.
    Baltes PB, Lindenberger U. Emergence of a powerful connection between sensory and cognitive functions across the adult life span: a new window to the study of cognitive aging? Psychol Aging. 1997;12:12–21.CrossRefGoogle Scholar
  29. 29.
    Armstrong RA. Alzheimer’s disease and the eye. J Optom. 2009;2:103–11.CrossRefGoogle Scholar
  30. 30.
    3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology. 2003;22:316–25.CrossRefGoogle Scholar
  31. 31.
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.CrossRefGoogle Scholar
  32. 32.
    Isaacs B, Kennie AT. The Set test as an aid to the detection of dementia in old people. Br J Psychiatry J Ment Sci. 1973;123:467–70.CrossRefGoogle Scholar
  33. 33.
    Benton A. Manuel pour l’application du test de retention visuelle. Applications cliniques et expérimentales. Deuxième édition française. Paris: Centre de Psychologie Appliquée; 1965.Google Scholar
  34. 34.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington DC: American Psychiatric Association; 1994.Google Scholar
  35. 35.
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34:939–44.CrossRefGoogle Scholar
  36. 36.
    Foubert-Samier A, Catheline G, Amieva H, Dilharreguy B, Helmer C, Allard M, et al. Education, occupation, leisure activities, and brain reserve: a population-based study. Neurobiol Aging. 2012;33(423):e15–25.Google Scholar
  37. 37.
    Akbaraly TN, Portet F, Fustinoni S, Dartigues J-F, Artero S, Rouaud O, et al. Leisure activities and the risk of dementia in the elderly: results from the Three-City Study. Neurology. 2009;73:854–61.CrossRefGoogle Scholar
  38. 38.
    Radloff LS. The CES-D Scale A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRefGoogle Scholar
  39. 39.
    Fuhrer R, Rouillon F. La version française de l’échelle CES-D (Center for epidemiologic studies-depression scale). Description et traduction de l’échelle d’autoévaluation. Psychiatr Psychobiol. 1989;4:163–6.Google Scholar
  40. 40.
    Lin FR, Metter EJ, O’Brien RJ, Resnick SM, Zonderman AB, Ferrucci L. Hearing loss and incident dementia. Arch Neurol. 2011;68:214–20.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Schafer JL. Multiple imputation: a primer: Stat Methods Med Res [Internet]. 2016 [cited 2018 Oct 26]; Available from: http://journals.sagepub.com/doi/metrics/10.1177/096228029900800102.
  42. 42.
    Bowen M, Edgar DF, Hancock B, Haque S, Shah R, Buchanan S, et al. The prevalence of visual impairment in people with dementia (the PrOVIDe study). Southampton: NIHR Journals Library; 2016.Google Scholar
  43. 43.
    Li C-M, Zhang X, Hoffman HJ, Cotch MF, Themann CL, Wilson MR. Hearing impairment associated with depression in US Adults, National Health and Nutrition Examination Survey 2005–2010. JAMA Otolaryngol Neck Surg. 2014;140:293–302.CrossRefGoogle Scholar
  44. 44.
    Cosh S, Carrière I, Daien V, Tzourio C, Delcourt C, Helmer C. Sensory loss and suicide ideation in older adults: findings from the Three-City cohort study. Int Psychogeriatr. 2018;1–7.Google Scholar
  45. 45.
    Baker ML, Wang JJ, Rogers S, Klein R, Kuller LH, Larsen EK, et al. Early age-related macular degeneration, cognitive function, and dementia: the Cardiovascular Health Study. Arch Ophthalmol Chic Ill. 1960;2009(127):667–73.Google Scholar
  46. 46.
    Naël V, Moreau G, Monfermé S, Cougnard-Grégoire A, Scherlen A-C, Arleo A, et al. Prevalence and associated factors of uncorrected refractive error in older adults in a population-based study in France. JAMA Ophthalmol. 2018.Google Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  • Virginie Naël
    • 1
    • 2
    • 3
    Email author
  • Karine Pérès
    • 1
  • Jean-François Dartigues
    • 1
    • 4
  • Luc Letenneur
    • 1
  • Hélène Amieva
    • 1
  • Angelo Arleo
    • 2
  • Anne-Catherine Scherlen
    • 3
  • Christophe Tzourio
    • 1
  • Claudine Berr
    • 5
  • Isabelle Carrière
    • 5
  • Cécile Delcourt
    • 1
  • Catherine Helmer
    • 1
  • the Sense-Cog consortium
  1. 1.Inserm, Bordeaux Population Health Research Center, UMR 1219Univ. BordeauxBordeauxFrance
  2. 2.UPMC University of Paris 06, INSERM, CNRS, Vision InstituteSorbonne UniversityParisFrance
  3. 3.R&D Life and Vision Science, Essilor InternationalParisFrance
  4. 4.Memory Consultation, CMRRBordeaux University HospitalBordeauxFrance
  5. 5.Inserm U1061University of MontpellierMontpellierFrance

Personalised recommendations